MENU
OKUR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
OnKure Therapeutics (OKUR) Ownership - Who owns OnKure Therapeutics?
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.07M
P/E Ratio
62.48
Total Cash
83.37M
Projected Growth
N/A
Total Debt
823K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.16
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
OKUR
Capitalization
37.1M
P/E Ratio
62.48
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
83.4M
Total Cash/Share
6.16
Total Debt
823K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
78.2M
P/B Ratio
0.47
Cash Flow
N/A
Earnings
-4.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
11.13
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-59.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-108.14
Shares Held By Institutions
35.2M
Shares Outstanding - Current
13.5M
Total Liabilities
7.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-67.442
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information